SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Aviron -- Ignore unavailable to you. Want to Upgrade?


To: SJS who wrote (219)4/27/1998 1:08:00 PM
From: Gerald Walls  Read Replies (1) | Respond to of 645
 
Aviron recommended by the May issue of Taipan, now on its web site.

Buy under: 25.
Six-month: 35-40
Two-year: 60

Says expects application in August with fast track approval (due to NIH involvement?) in two months. Speculates inhaled flu vaccine may become mandated for school children. (I personally have problems with that but me not buying the stock won't change it.)

It looks to me that a violation of 20 would be a Bad Thing for AVIR.